We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Says Diabetes Drugs Onglyza, Nesina May Increase Heart Failure Risk

(April 6, 2016, 11:20 AM EDT) -- SILVER SPRING, Md. — The diabetes drugs Onglyza and Nesina may increase the risk of heart failure, particularly in patients who already have heart or kidney disease, the Food and Drug...
To view the full article, register now.